G 531 (Bendroflumethiazide and nadolol 5 mg / 40 mg)
Pill imprint G 531 has been identified as Bendroflumethiazide and nadolol 5 mg / 40 mg.
Bendroflumethiazide/nadolol is used in the treatment of high blood pressure and belongs to the drug class beta blockers with thiazides. Risk cannot be ruled out during pregnancy. Bendroflumethiazide/nadolol 5 mg / 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- G 531
- 5 mg / 40 mg
- Prescription only
- Drug Class:
- Beta blockers with thiazides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Global Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
Note: Inactive ingredients may vary.
More about bendroflumethiazide/nadolol
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 1 Review – Add your own review/rating
- Drug class: beta blockers with thiazides
- Bendroflumethiazide and nadolol
- Nadolol and bendroflumethiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.